These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

571 related articles for article (PubMed ID: 27199363)

  • 21. Detecting Vulnerable Atherosclerotic Plaques by
    Jiang L; Zhu H; Li Y; Wu X; Wang H; Cheng Z
    Mol Pharm; 2019 Mar; 16(3):1350-1357. PubMed ID: 30742442
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Quantification of inflammation within rabbit atherosclerotic plaques using the macrophage-specific CT contrast agent N1177: a comparison with 18F-FDG PET/CT and histology.
    Hyafil F; Cornily JC; Rudd JH; Machac J; Feldman LJ; Fayad ZA
    J Nucl Med; 2009 Jun; 50(6):959-65. PubMed ID: 19443582
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular and cellular targets of the MRI contrast agent P947 for atherosclerosis imaging.
    Ouimet T; Lancelot E; Hyafil F; Rienzo M; Deux F; Lemaître M; Duquesnoy S; Garot J; Roques BP; Michel JB; Corot C; Ballet S
    Mol Pharm; 2012 Apr; 9(4):850-61. PubMed ID: 22352457
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular Imaging of Inflammation in a Mouse Model of Atherosclerosis Using a Zirconium-89-Labeled Probe.
    Ahmed M; Tegnebratt T; Tran TA; Lu L; Damberg P; Gisterå A; Tarnawski L; Bone D; Hedin U; Eriksson P; Holmin S; Gustafsson B; Caidahl K
    Int J Nanomedicine; 2020; 15():6137-6152. PubMed ID: 32884268
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of alphavbeta3 integrin-targeted positron emission tomography tracer 18F-galacto-RGD for imaging of vascular inflammation in atherosclerotic mice.
    Laitinen I; Saraste A; Weidl E; Poethko T; Weber AW; Nekolla SG; Leppänen P; Ylä-Herttuala S; Hölzlwimmer G; Walch A; Esposito I; Wester HJ; Knuuti J; Schwaiger M
    Circ Cardiovasc Imaging; 2009 Jul; 2(4):331-8. PubMed ID: 19808614
    [TBL] [Abstract][Full Text] [Related]  

  • 26. RGD targeting of human ferritin iron oxide nanoparticles enhances in vivo MRI of vascular inflammation and angiogenesis in experimental carotid disease and abdominal aortic aneurysm.
    Kitagawa T; Kosuge H; Uchida M; Iida Y; Dalman RL; Douglas T; McConnell MV
    J Magn Reson Imaging; 2017 Apr; 45(4):1144-1153. PubMed ID: 27689830
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Non-invasive Imaging of Idiopathic Pulmonary Fibrosis Using Cathepsin Protease Probes.
    Withana NP; Ma X; McGuire HM; Verdoes M; van der Linden WA; Ofori LO; Zhang R; Li H; Sanman LE; Wei K; Yao S; Wu P; Li F; Huang H; Xu Z; Wolters PJ; Rosen GD; Collard HR; Zhu Z; Cheng Z; Bogyo M
    Sci Rep; 2016 Jan; 6():19755. PubMed ID: 26797565
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Non-invasive imaging of cysteine cathepsin activity in solid tumors using a 64Cu-labeled activity-based probe.
    Ren G; Blum G; Verdoes M; Liu H; Syed S; Edgington LE; Gheysens O; Miao Z; Jiang H; Gambhir SS; Bogyo M; Cheng Z
    PLoS One; 2011; 6(11):e28029. PubMed ID: 22132198
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Validity of dual MRI and F-FDG PET imaging in predicting vulnerable and inflamed carotid plaque.
    Saito H; Kuroda S; Hirata K; Magota K; Shiga T; Tamaki N; Yoshida D; Terae S; Nakayama N; Houkin K
    Cerebrovasc Dis; 2013; 35(4):370-7. PubMed ID: 23635390
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Higher reliability of 18F-FDG target background ratio compared to standardized uptake value in vulnerable carotid plaque detection: a pilot study.
    Niccoli Asabella A; Ciccone MM; Cortese F; Scicchitano P; Gesualdo M; Zito A; Di Palo A; Angiletta D; Regina G; Marzullo A; Rubini G
    Ann Nucl Med; 2014 Jul; 28(6):571-9. PubMed ID: 24737136
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 64Cu-DOTATATE PET/MRI for Detection of Activated Macrophages in Carotid Atherosclerotic Plaques: Studies in Patients Undergoing Endarterectomy.
    Pedersen SF; Sandholt BV; Keller SH; Hansen AE; Clemmensen AE; Sillesen H; Højgaard L; Ripa RS; Kjær A
    Arterioscler Thromb Vasc Biol; 2015 Jul; 35(7):1696-703. PubMed ID: 25977567
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Positron Emission Tomography Imaging of Macrophages in Atherosclerosis with
    Hellberg S; Liljenbäck H; Eskola O; Morisson-Iveson V; Morrison M; Trigg W; Saukko P; Ylä-Herttuala S; Knuuti J; Saraste A; Roivainen A
    Contrast Media Mol Imaging; 2018; 2018():9186902. PubMed ID: 29950954
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Atherosclerosis inflammation imaging with 18F-FDG PET: carotid, iliac, and femoral uptake reproducibility, quantification methods, and recommendations.
    Rudd JH; Myers KS; Bansilal S; Machac J; Pinto CA; Tong C; Rafique A; Hargeaves R; Farkouh M; Fuster V; Fayad ZA
    J Nucl Med; 2008 Jun; 49(6):871-8. PubMed ID: 18483100
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Targeting P-selectin by gallium-68-labeled fucoidan positron emission tomography for noninvasive characterization of vulnerable plaques: correlation with in vivo 17.6T MRI.
    Li X; Bauer W; Israel I; Kreissl MC; Weirather J; Richter D; Bauer E; Herold V; Jakob P; Buck A; Frantz S; Samnick S
    Arterioscler Thromb Vasc Biol; 2014 Aug; 34(8):1661-7. PubMed ID: 24903095
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular imaging of atherosclerotic plaques targeted to oxidized LDL receptor LOX-1 by SPECT/CT and magnetic resonance.
    Li D; Patel AR; Klibanov AL; Kramer CM; Ruiz M; Kang BY; Mehta JL; Beller GA; Glover DK; Meyer CH
    Circ Cardiovasc Imaging; 2010 Jul; 3(4):464-72. PubMed ID: 20442371
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunoglobulin G (IgG)-Based Imaging Probe Accumulates in M1 Macrophage-Infiltrated Atherosclerotic Plaques Independent of IgG Target Molecule Expression.
    Shimizu Y; Hanzawa H; Zhao Y; Fukura S; Nishijima KI; Sakamoto T; Zhao S; Tamaki N; Ogawa M; Kuge Y
    Mol Imaging Biol; 2017 Aug; 19(4):531-539. PubMed ID: 27981470
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dual-modality Imaging of Angiogenesis in Unstable Atherosclerotic Plaques with VEGFR2-Targeted Upconversion Nanoprobes in vivo.
    Fang Y; Yang R; Hou Y; Wang Y; Yang N; Xu M; Li S; Gao S; Jiang M; Fan J; Hu Y; Xu Z; Gao L; Cao F
    Mol Imaging Biol; 2022 Oct; 24(5):721-731. PubMed ID: 35604528
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cysteine-type cathepsins promote the effector phase of acute cutaneous delayed-type hypersensitivity reactions.
    Schwenck J; Maurer A; Fehrenbacher B; Mehling R; Knopf P; Mucha N; Haupt D; Fuchs K; Griessinger CM; Bukala D; Holstein J; Schaller M; Menendez IG; Ghoreschi K; Quintanilla-Martinez L; Gütschow M; Laufer S; Reinheckel T; Röcken M; Kalbacher H; Pichler BJ; Kneilling M
    Theranostics; 2019; 9(13):3903-3917. PubMed ID: 31281521
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cathepsin V, a novel and potent elastolytic activity expressed in activated macrophages.
    Yasuda Y; Li Z; Greenbaum D; Bogyo M; Weber E; Brömme D
    J Biol Chem; 2004 Aug; 279(35):36761-70. PubMed ID: 15192101
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.